Business Courier: Music in future will require innovation
Choral director and UC alumna is optimistic about the future of choruses
University of Cincinnati alumna Danielle Cozart Steele assumes her new position as artistic director of the Young Professionals Choral Collective in unprecedented times.
Although medical experts say it won’t be safe for choruses to return to singing together until there is a vaccine for Covid-19, Steele told the Cincinnati Business Courier that she's both energized and optimistic.
“Historically the most interesting and best art has come out of periods of great turmoil and strife,” said Steele, who earned a master’s degree in vocal performance at UC's College-Conservatory of Music. “This is our moment to be a leader as we reconceptualize what it means to be a choral organization when you can’t do mass gatherings — at least for a period of time.”
Featured image at top: Danielle Cozart Steele is the new artistic director of the Young Professionals Choral Collective. Photo/courtesy of YPCC
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.